1948 related articles for article (PubMed ID: 34621267)
1. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
2. The second brain: The connection between gut microbiota composition and multiple sclerosis.
Farshbafnadi M; Agah E; Rezaei N
J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Yadav SK; Ito K; Dhib-Jalbut S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
[TBL] [Abstract][Full Text] [Related]
4. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
5. Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.
Zhang ML; Li WX; Wang XY; Wu YL; Chen XF; Zhang H; Yang LQ; Wu CZ; Zhang SQ; Chen YL; Feng KR; Wang B; Niu L; Kong DX; Tang JF
Front Cell Infect Microbiol; 2022; 12():1095053. PubMed ID: 36710971
[TBL] [Abstract][Full Text] [Related]
6. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.
Dopkins N; Nagarkatti PS; Nagarkatti M
Immunology; 2018 Jun; 154(2):178-185. PubMed ID: 29392733
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
Saresella M; Marventano I; Barone M; La Rosa F; Piancone F; Mendozzi L; d'Arma A; Rossi V; Pugnetti L; Roda G; Casagni E; Cas MD; Paroni R; Brigidi P; Turroni S; Clerici M
Front Immunol; 2020; 11():1390. PubMed ID: 32733460
[No Abstract] [Full Text] [Related]
8. Targeting the gut to treat multiple sclerosis.
Ghezzi L; Cantoni C; Pinget GV; Zhou Y; Piccio L
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196310
[TBL] [Abstract][Full Text] [Related]
9. Treatment with the Olive Secoiridoid Oleacein Protects against the Intestinal Alterations Associated with EAE.
Gutiérrez-Miranda B; Gallardo I; Melliou E; Cabero I; Álvarez Y; Hernández M; Magiatis P; Hernández M; Nieto ML
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902407
[TBL] [Abstract][Full Text] [Related]
10. Impacts of microbiome metabolites on immune regulation and autoimmunity.
Haase S; Haghikia A; Wilck N; Müller DN; Linker RA
Immunology; 2018 Jun; 154(2):230-238. PubMed ID: 29637999
[TBL] [Abstract][Full Text] [Related]
11. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
[TBL] [Abstract][Full Text] [Related]
12. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
Rutsch A; Kantsjö JB; Ronchi F
Front Immunol; 2020; 11():604179. PubMed ID: 33362788
[TBL] [Abstract][Full Text] [Related]
13. The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
Kumar N; Sahoo NK; Mehan S; Verma B
Mult Scler Relat Disord; 2023 Mar; 71():104547. PubMed ID: 36805171
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
15. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
16. Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
Nouri M; Bredberg A; Weström B; Lavasani S
PLoS One; 2014; 9(9):e106335. PubMed ID: 25184418
[TBL] [Abstract][Full Text] [Related]
17. Naringenin confers protection against experimental autoimmune encephalomyelitis through modulating the gut-brain axis: A multiomics analysis.
Liu Z; Sun M; Jin C; Sun X; Feng F; Niu X; Wang B; Zhang Y; Wang J
J Nutr Biochem; 2023 Dec; 122():109448. PubMed ID: 37741298
[TBL] [Abstract][Full Text] [Related]
18. ILC3, a Central Innate Immune Component of the Gut-Brain Axis in Multiple Sclerosis.
Miljković Đ; Jevtić B; Stojanović I; Dimitrijević M
Front Immunol; 2021; 12():657622. PubMed ID: 33912185
[TBL] [Abstract][Full Text] [Related]
19. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
20. The role of the gut microbiota and microbial metabolites in neuroinflammation.
Haase S; Wilck N; Haghikia A; Gold R; Mueller DN; Linker RA
Eur J Immunol; 2020 Dec; 50(12):1863-1870. PubMed ID: 33188704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
